NeuBase: Fiscal Q2 Earnings Snapshot
Business News
Thu, May 12, 2022 5:28 PM
STATS Perform dba Automated Insights
PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $9.9 million in its fiscal second quarter.
On a per-share basis, the Pittsburgh-based company said it had a loss of 30 cents.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE